ANDAs Must Include All Bioequivalence Data: FDA
By Sara Stefanini · January 20, 2009, 12:00 AM EST
The U.S. Food and Drug Administration issued a final rule Tuesday requiring pharmaceutical companies that apply to sell generic medications to provide data from all the bioequivalence studies they conduct on...
To view the full article, register now.